FI903214A0 - Naftyl- och naftyloxi- pyrimidiner och dessa beroerande foereningar, foerfarande foer deras framstaellning och deras anvaendning som dermatologiska laekemedel. - Google Patents

Naftyl- och naftyloxi- pyrimidiner och dessa beroerande foereningar, foerfarande foer deras framstaellning och deras anvaendning som dermatologiska laekemedel.

Info

Publication number
FI903214A0
FI903214A0 FI903214A FI903214A FI903214A0 FI 903214 A0 FI903214 A0 FI 903214A0 FI 903214 A FI903214 A FI 903214A FI 903214 A FI903214 A FI 903214A FI 903214 A0 FI903214 A0 FI 903214A0
Authority
FI
Finland
Prior art keywords
och
deras
naftyloxi
dermatologiska
beroerande
Prior art date
Application number
FI903214A
Other languages
English (en)
Inventor
Richard Charles Effland
Joseph Thomas Klein
Gordon Edward Olsen
Larry Davis
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI903214A0 publication Critical patent/FI903214A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/68One oxygen atom attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI903214A 1989-06-28 1990-06-26 Naftyl- och naftyloxi- pyrimidiner och dessa beroerande foereningar, foerfarande foer deras framstaellning och deras anvaendning som dermatologiska laekemedel. FI903214A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90/002767A US4931457B1 (en) 1989-06-28 1989-06-28 Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders

Publications (1)

Publication Number Publication Date
FI903214A0 true FI903214A0 (fi) 1990-06-26

Family

ID=23468431

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903214A FI903214A0 (fi) 1989-06-28 1990-06-26 Naftyl- och naftyloxi- pyrimidiner och dessa beroerande foereningar, foerfarande foer deras framstaellning och deras anvaendning som dermatologiska laekemedel.

Country Status (12)

Country Link
US (1) US4931457B1 (fi)
EP (1) EP0405426A3 (fi)
JP (1) JPH0338567A (fi)
KR (1) KR910000647A (fi)
AU (1) AU5784790A (fi)
CA (1) CA2019624A1 (fi)
FI (1) FI903214A0 (fi)
IE (1) IE902330A1 (fi)
IL (1) IL94876A0 (fi)
NO (1) NO902861L (fi)
PT (1) PT94502A (fi)
ZA (1) ZA905001B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3837809A1 (de) * 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
TW200462B (fi) * 1990-09-27 1993-02-21 Hoechst Roussel Pharma
US5581010A (en) * 1994-07-22 1996-12-03 Rockwell International Corporation Semi-organic crystals for nonlinear optical devices
BRPI9807848B8 (pt) * 1997-02-21 2016-05-31 Bayer Schering Pharma Ag compostos de arilsulfonamidas e análogos, bem como composição farmacêutica e uso dos mesmos.
DE19740785A1 (de) * 1997-02-21 1998-08-27 Bayer Ag Arylsulfonamide und Analoga
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
PT1889198E (pt) 2005-04-28 2015-03-06 Proteus Digital Health Inc Sistema fármaco-informático
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3118884A (en) * 1959-10-19 1964-01-21 Schering Corp Derivatives of 3-azaphenothiazine and 3-azaphenoxazine
US3495969A (en) * 1967-09-25 1970-02-17 Mobil Oil Corp Substituted nitropyridines as herbicides
US3576616A (en) * 1969-05-15 1971-04-27 Monsanto Co Herbicidal compositions and methods
US3721676A (en) * 1969-11-12 1973-03-20 Merck & Co Inc Certain 3-amino-2(1h)pyridones
EP0000816A1 (en) * 1977-08-06 1979-02-21 Beecham Group Plc Substituted amino-pyridine derivatives, processes for their preparation and pharmaceutical compositions containing them
GB2073736B (en) * 1979-10-03 1984-02-01 Ici Ltd Process for preparing pyridinyloxyphenoxy compounds and derivatives thereof
US4521426A (en) * 1982-09-30 1985-06-04 Union Carbide Corporation Pesticidal bicyclooxyheterocyclyl aroyl ureas
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds

Also Published As

Publication number Publication date
EP0405426A2 (en) 1991-01-02
NO902861L (no) 1991-01-02
US4931457B1 (en) 1993-11-16
IE902330A1 (en) 1991-01-16
NO902861D0 (no) 1990-06-27
PT94502A (pt) 1991-02-08
ZA905001B (en) 1991-03-27
JPH0338567A (ja) 1991-02-19
IE902330L (en) 1990-12-28
US4931457A (en) 1990-06-05
AU5784790A (en) 1991-01-03
EP0405426A3 (en) 1992-05-13
CA2019624A1 (en) 1990-12-28
IL94876A0 (en) 1991-04-15
KR910000647A (ko) 1991-01-29

Similar Documents

Publication Publication Date Title
FI904419A0 (fi) 3-(1-substituerade-4-piperazinyl)- 1h-indazoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI915387A (fi) Tuggummi, som avger smak under en foerlaengd tidsperiod och som innehaoller omaettade, renade monoglycerider.
FI903845A0 (fi) Renininhibitorer, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI922454A0 (fi) Peptider och antikroppar som inhiberar integrinligandbindning.
FI922277A (fi) Icke-replicerande, medelst rekombinant-teknik framstaellda retrovirala partiklar, vilka anvaendes som antivirala medel och immunogener.
FI903028A0 (fi) Polymerbaserade blandningskompositioner, som innehaoller destrukturerad staerkelse.
FI902248A0 (fi) N-heteroaryl-4-kinolinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI906139A (fi) Halogenerade olefiner, foerfarande foer framstaellning av dessa och anvaendning av dessa som skadedjursbekaempningsmedel.
FI891411A (fi) Neopentylesterderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI903214A0 (fi) Naftyl- och naftyloxi- pyrimidiner och dessa beroerande foereningar, foerfarande foer deras framstaellning och deras anvaendning som dermatologiska laekemedel.
FI905020A0 (fi) Orala kompositioner, som innehaoller monoperoxisyror.
FI905689A (fi) 3-aminopyrroler, foerfaranden foer deras framstaellning, och deras anvaendning som laekemedel.
FI914556A0 (fi) 4- eller 5-substituerade pyridiner-2-karboxylsyror, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI904660A0 (fi) Som fungicider anvaendbara substituerade triazoler, deras framstaellning och kompositioner.
FI905702A0 (fi) Kumarinderivat, foerfarande foer framstaellning av dessa, anvaendning av dessa och tiazolylaettikssyraderivat som mellanprodukter.
FI882443A (fi) Substituerade vinylkefalosporiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI890098A0 (fi) Pyrazol- och indazolpyridinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI902852A0 (fi) Renininhibitoriska peptider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI902199A0 (fi) 5-substituerade 3-aryl-isoxazolderivat, deras framstaellning och deras anvaendning som skadedjursbekaempningsmedel.
FI903630A0 (fi) Fluoranfoereningar, deras kristallina toluenaddukter, dessa innehaollande upptagningsmaterial och foerfarande foer deras framstaellning.
FI901461A0 (fi) Underrede foer raelsfoerbundna godsvagn, saerskilt foer tankvagnar och kapslade bulkgodsvagnar.
FI881873A (fi) Kondenserade heteroalkylenkinolinaminer, foerfarande och mellanprodukter foer deras framstaellning och deras anvaendning som laekemedel.
FI891409A0 (fi) Dietylenglykolmonoestrar, foerfaranden foer deras framstaellning och deras framstaellning och deras anvaendning som laekemedel.
FI903851A0 (fi) Vinyliden- och etylenfluoridkopolymer, dess framstaellningsfoerfarande och tillaempning som adhesionmedium.
FI902177A0 (fi) Kompositioner som innehaoller elastomerer och icke-karboniserade, metaller innehaollande komplex.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED